- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
CLES 2006 provides forum for information exchange
Approximately 1,000 attendees from 43 states and from 13 countries contributed to the success of the fourth annual Contact Lens and Eyecare Symposium (CLES). CLES 2006 took place Jan. 11 to 15 at the Royal Pacific Resort at Universal in Orlando.
The latest edition of CLES served as a forum for information exchange on contact lens research, clinical issues, and strategies for practice growth.
"CLES has emerged as the premier education meeting focused on contact lenses and lens care," said Ed Schilling, executive director of the Contact Lens Institute, host organization of CLES.
The notable CLES faculty provided 4 days of leading-edge education focused on all aspects of contact lenses, eye care, patient care, and practice building.
Another successful aspect of the conference was the exhibit hall, where representatives of more than 45 manufacturers, service providers, and associations occupied 75 booths.
Several receptions and social events were also held in the exhibit hall.
More than 300 eye-care professionals attended each of four plenary sessions, which kicked off with "Myopia: New Treatment Options and the Future of Eye Care," chaired by Brien Holden, PhD.
"We could not have been more pleased by the open exchange of information that will help us all to meet our ultimate goal: to serve our patients best," said Richard E. Weisbarth, OD, CLES education chairman, in a prepared statement.
CLES was sponsored by the Contact Lens Institute (CLI), whose members include: Advanced Medical Optics (AMO), Alcon Laboratories, Bausch & Lomb, CIBA Vision, CooperVision, and Vistakon.
